Analysts Predict 14% Growth Potential for SCHV
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 07 2025
0mins
Source: NASDAQ.COM
ETF Analysis: The Schwab U.S. Large-Cap Value ETF (SCHV) has an implied analyst target price of $32.80 per unit, indicating a potential upside of 14.09% from its recent trading price of $28.75.
Notable Holdings: Key underlying holdings with significant upside potential include AMRIZE LTD (AMRZ), Estee Lauder (EL), and CRH plc, with expected price increases of 15.43%, 14.52%, and 14.15% respectively.
Analyst Target Justification: The article raises questions about whether analysts' target prices are justified or overly optimistic, suggesting that high targets may lead to downgrades if they do not align with current market conditions.
Investor Research: Investors are encouraged to conduct further research to assess the validity of analyst targets in light of recent developments in the companies and their industries.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy EL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on EL
Wall Street analysts forecast EL stock price to rise
18 Analyst Rating
8 Buy
9 Hold
1 Sell
Moderate Buy
Current: 82.470
Low
70.00
Averages
106.76
High
130.00
Current: 82.470
Low
70.00
Averages
106.76
High
130.00
About EL
The Estee Lauder Companies Inc. is a manufacturer, marketer and seller of skin care, makeup, fragrance and hair care products. Its products are sold in over 150 countries and territories under a number of brand names, including Estee Lauder, Aramis, Clinique, Lab Series, Origins, M.A.C, Bobbi Brown Cosmetics, La Mer, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frederic Malle, GLAMGLOW, Kilian Paris, Too Faced, Dr.Jart+, and the DECIEM family of brands, including The Ordinary and NIOD, and BALMAIN Beauty. It is a license for fragrances, cosmetics and/or related products for AERIN, BALMAIN, and Dr. Andrew Weil. Its skin care products include moisturizers, serums, cleansers, toners, exfoliators, facial masks, body care, sun care products and others. Its makeup products include foundations, powders, concealers and setting sprays, lipsticks, lip liners and lip glosses, and mascaras, eyeshadows and eyeliners.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
L'Oreal Expands into Mass-Market Fragrances
- Market Expansion Strategy: L'Oreal is launching NYX-branded hair and body mists priced at around $15 for 80ml, targeting younger consumers, particularly Gen Z interested in K-Beauty trends, which is expected to significantly enhance the brand's share in this rapidly growing market.
- Sales Growth Potential: While luxury fragrance sales are achieving double-digit growth, the mass-market fragrance sector saw a 15% increase in retail sales last year, indicating stronger market demand, and L'Oreal's new product line is poised to capitalize on this opportunity to capture market share.
- Innovation-Driven Plan: In response to a slowdown in growth over the past few years, CEO Nicolas Hieronimus launched a
See More
Meta Launches AI Smart Glasses Starting at $299
- Significant Price Reduction: Meta's new AI smart glasses, launched in partnership with EssilorLuxottica, start at just $299, a substantial decrease from the previous Ray-Ban Display glasses priced at $800, which is expected to attract more consumers and expand market share.
- Brand Strategy Shift: Unlike previous models, the new glasses will not carry Ray-Ban or Oakley branding but will be marketed as Meta Glasses, a strategy aimed at strengthening the Meta brand image and enhancing consumer recognition of its products.
- Technological Innovation: The Meta Glasses are the first to feature the Muse Spark technology, marking a significant advancement in Meta's smart glasses offerings, which could lead the industry and prompt competitors to accelerate their product development.
- Market Dominance: According to IDC, Meta held a 76.1% share of global smart glasses shipments last year, with a total of 9.6 million units shipped, further solidifying its competitive advantage in the smart device sector.
See More
Meta Launches New Line of AI Smart Glasses
- New Product Launch: Meta debuted its new line of AI smart glasses priced at $299, aiming to expand market reach by offering a more competitive price point compared to higher-end products from Ray-Ban and Oakley.
- Market Share Control: According to Counterpoint Research, Meta currently holds about 80% of the AI glasses market share, and despite challenges from competitors like Google and Apple, the company is focused on solidifying its market leadership.
- Product Diversification: The new Meta glasses come in three styles, including a collaboration with Kylie Jenner priced at $399, which adds a personalized AI assistant feature to attract a broader consumer base.
- Technological Investment: Meta plans to invest over $145 billion in AI-related hardware by 2026, and while the market remains cautious about its spending, the company is committed to demonstrating the value of its investments through innovation.
See More
Market Dynamics and Corporate Mergers Overview
- Muted Market Start: The new trading week begins with the S&P 500 indicated flat while the tech-heavy Nasdaq shows slight gains, and WTI crude oil is trading around $76.50 per barrel, reflecting cautious market sentiment regarding economic outlook.
- Abbvie Acquires Apogee: Abbvie is acquiring Apogee Therapeutics for $10.9 billion to strengthen its immunology portfolio, particularly competing with Johnson & Johnson's Tremfya through its top drug Skyrizi, which is expected to enhance Abbvie's competitive edge in the biopharmaceutical market.
- CRH Acquires Arcosa: CRH is acquiring Arcosa for $8.5 billion, stating that the acquisition is highly complementary amid growing demand for energy and utility infrastructure, which is expected to further solidify CRH's position in the construction materials market.
- Estee Lauder Buy Rating Reinstated: Goldman Sachs has reinstated a buy rating for Estee Lauder with a price target of $100, as analysts believe the market is underestimating the company's growth momentum, especially after it walked away from merger talks with Spanish beauty peer Puig.
See More
Key Wall Street Rating Updates on Monday
- Tesla Rating Maintained: Jefferies raised Tesla's price target from $350 to $375, indicating that the stock did not sell off ahead of the SPCX IPO, which suggests a consensus on a potential merger that could turn TSLA into a tracker to minimize shareholder dilution risk.
- Kimco Realty Upgrade: Wolfe upgraded Kimco Realty from Peer Perform to Outperform with a price target of $28, anticipating approximately a 16% total return, reflecting strong fundamentals and signaling a recovery potential in the real estate market.
- Cleveland-Cliffs Downgrade: Morgan Stanley downgraded Cleveland-Cliffs from Overweight to Equal Weight with a new price target of $12.5, indicating a more balanced risk-reward profile in line with peers, reflecting a cautious market sentiment towards the stock.
- Micron Technology Reiteration: Bernstein raised Micron's price target from $510 to $1,300 while maintaining an Outperform rating, driven by optimistic forecasts for conventional memory and high bandwidth memory pricing, highlighting a robust recovery in the semiconductor sector.
See More
Ulta Beauty Accelerates Fragrance Business Growth
- Fragrance Category Growth: In Q1 of fiscal 2026, Ulta Beauty achieved high-teen comp growth in its fragrance category, increasing its revenue share from 11% to 12%, indicating robust performance and sustained growth potential in the fragrance market.
- New Product Sales Boost: The introduction of new products from core luxury brands like YSL, Carolina Herrera, and Valentino, along with NOYZ's innovative milk scent format, significantly enhanced customer interest and drove sales growth, showcasing the company's success in product innovation.
- Marketing Strategy: NOYZ's 360-degree go-to-market activation strategy propelled it into Ulta's top 20 fragrance brands, while the collaboration fragrance “Be Her” with Ella Langley increased brand social engagement, further enhancing consumer awareness and interest.
- Financial Performance Analysis: Despite a 3.8% decline in Ulta's stock price over the past year, its forward P/E ratio of 15.23 is slightly above the industry average of 14.39, reflecting market confidence in its future growth, with earnings expected to rise by 11.8% and 11.3% over the next two fiscal years.
See More
L'Oreal Expands into Mass-Market Fragrances
- Market Expansion Strategy: L'Oreal is launching NYX-branded hair and body mists priced at around $15 for 80ml, targeting younger consumers, particularly Gen Z interested in K-Beauty trends, which is expected to significantly enhance the brand's share in this rapidly growing market.
- Sales Growth Potential: While luxury fragrance sales are achieving double-digit growth, the mass-market fragrance sector saw a 15% increase in retail sales last year, indicating stronger market demand, and L'Oreal's new product line is poised to capitalize on this opportunity to capture market share.
- Innovation-Driven Plan: In response to a slowdown in growth over the past few years, CEO Nicolas Hieronimus launched a
See More
Meta Launches AI Smart Glasses Starting at $299
- Significant Price Reduction: Meta's new AI smart glasses, launched in partnership with EssilorLuxottica, start at just $299, a substantial decrease from the previous Ray-Ban Display glasses priced at $800, which is expected to attract more consumers and expand market share.
- Brand Strategy Shift: Unlike previous models, the new glasses will not carry Ray-Ban or Oakley branding but will be marketed as Meta Glasses, a strategy aimed at strengthening the Meta brand image and enhancing consumer recognition of its products.
- Technological Innovation: The Meta Glasses are the first to feature the Muse Spark technology, marking a significant advancement in Meta's smart glasses offerings, which could lead the industry and prompt competitors to accelerate their product development.
- Market Dominance: According to IDC, Meta held a 76.1% share of global smart glasses shipments last year, with a total of 9.6 million units shipped, further solidifying its competitive advantage in the smart device sector.
See More
Meta Launches New Line of AI Smart Glasses
- New Product Launch: Meta debuted its new line of AI smart glasses priced at $299, aiming to expand market reach by offering a more competitive price point compared to higher-end products from Ray-Ban and Oakley.
- Market Share Control: According to Counterpoint Research, Meta currently holds about 80% of the AI glasses market share, and despite challenges from competitors like Google and Apple, the company is focused on solidifying its market leadership.
- Product Diversification: The new Meta glasses come in three styles, including a collaboration with Kylie Jenner priced at $399, which adds a personalized AI assistant feature to attract a broader consumer base.
- Technological Investment: Meta plans to invest over $145 billion in AI-related hardware by 2026, and while the market remains cautious about its spending, the company is committed to demonstrating the value of its investments through innovation.
See More
Market Dynamics and Corporate Mergers Overview
- Muted Market Start: The new trading week begins with the S&P 500 indicated flat while the tech-heavy Nasdaq shows slight gains, and WTI crude oil is trading around $76.50 per barrel, reflecting cautious market sentiment regarding economic outlook.
- Abbvie Acquires Apogee: Abbvie is acquiring Apogee Therapeutics for $10.9 billion to strengthen its immunology portfolio, particularly competing with Johnson & Johnson's Tremfya through its top drug Skyrizi, which is expected to enhance Abbvie's competitive edge in the biopharmaceutical market.
- CRH Acquires Arcosa: CRH is acquiring Arcosa for $8.5 billion, stating that the acquisition is highly complementary amid growing demand for energy and utility infrastructure, which is expected to further solidify CRH's position in the construction materials market.
- Estee Lauder Buy Rating Reinstated: Goldman Sachs has reinstated a buy rating for Estee Lauder with a price target of $100, as analysts believe the market is underestimating the company's growth momentum, especially after it walked away from merger talks with Spanish beauty peer Puig.
See More
Key Wall Street Rating Updates on Monday
- Tesla Rating Maintained: Jefferies raised Tesla's price target from $350 to $375, indicating that the stock did not sell off ahead of the SPCX IPO, which suggests a consensus on a potential merger that could turn TSLA into a tracker to minimize shareholder dilution risk.
- Kimco Realty Upgrade: Wolfe upgraded Kimco Realty from Peer Perform to Outperform with a price target of $28, anticipating approximately a 16% total return, reflecting strong fundamentals and signaling a recovery potential in the real estate market.
- Cleveland-Cliffs Downgrade: Morgan Stanley downgraded Cleveland-Cliffs from Overweight to Equal Weight with a new price target of $12.5, indicating a more balanced risk-reward profile in line with peers, reflecting a cautious market sentiment towards the stock.
- Micron Technology Reiteration: Bernstein raised Micron's price target from $510 to $1,300 while maintaining an Outperform rating, driven by optimistic forecasts for conventional memory and high bandwidth memory pricing, highlighting a robust recovery in the semiconductor sector.
See More
Ulta Beauty Accelerates Fragrance Business Growth
- Fragrance Category Growth: In Q1 of fiscal 2026, Ulta Beauty achieved high-teen comp growth in its fragrance category, increasing its revenue share from 11% to 12%, indicating robust performance and sustained growth potential in the fragrance market.
- New Product Sales Boost: The introduction of new products from core luxury brands like YSL, Carolina Herrera, and Valentino, along with NOYZ's innovative milk scent format, significantly enhanced customer interest and drove sales growth, showcasing the company's success in product innovation.
- Marketing Strategy: NOYZ's 360-degree go-to-market activation strategy propelled it into Ulta's top 20 fragrance brands, while the collaboration fragrance “Be Her” with Ella Langley increased brand social engagement, further enhancing consumer awareness and interest.
- Financial Performance Analysis: Despite a 3.8% decline in Ulta's stock price over the past year, its forward P/E ratio of 15.23 is slightly above the industry average of 14.39, reflecting market confidence in its future growth, with earnings expected to rise by 11.8% and 11.3% over the next two fiscal years.
See More
